Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

Background: Behçet's disease is a multisystem vasculitis of unknown origin. Standard treatment mainly comprises systemic immunosuppressive agents. Ocular involvement, mostly posterior uveitis with retinal vasculitis, leads to blindness in 20–50% of the involved eyes within 5 years. The efficacy...

詳細記述

保存先:
書誌詳細
主要な著者: Kötter, I, Zierhut, M, Eckstein, A K, Vonthein, R, Ness, T, Günaydin, I, Grimbacher, B, Blaschke, S, Meyer-Riemann, W, Peter, H H, Stübiger, N
フォーマット: Artigo
言語:Inglês
出版事項: Copyright 2003 British Journal of Ophthalmology 2003
主題:
Clinical Science
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1771623/
https://ncbi.nlm.nih.gov/pubmed/12642304
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料